An electronic nose has been devised which is capable of sniffing out cancerous presence in the breath of patients. The tool can tell apart those who are disease-ridden from people in good health. Researchers deem that this breath-testing tool could be particularly beneficial for those people having head and neck cancer that are mostly identified in the later staging. Scientists from Israel did a collection of breath samples drawn from eighty-two individuals that were having cancer of the lungs, head and neck cancer or not having cancer at all. Helming the trial which appeared in the ‘Journal of Cancer Research’, Prof. H. Haick at the Israel Inst. of Technology, Technion stated that there is pressing requirement for developing novel means of detecting head and neck cancer since diagnosing  [...]

Being diagnosed with throat cancer translates to the fact that the larynx – the throat’s constitution which facilitates proper speaking, breathing and swallowing has developed malignance. Since their functioning is of utmost importance hence latest advancements in throat cancer treatment are focussed on preservation of as much functioning as doable. Quality of existence stays the prime focus even in later staging of the disease. Comprehending what the causes are of the disease, sooner identification and novel techniques have been contributory towards attaining this objective. Causes and Preventative Measures Smokers and alcohol drinkers are at the highest risk of developing laryngeal cancer (or cancer of the larynx or voice box) – a throat cancer type widespread among males. But  [...]

Majority of the cases of advanced staging head and neck cancer need chemotherapy employing drug cisplatin which is an inert platinum agent that hampers cancer development. A sizeable populace of patients fails in responding favorably to this form of treatment; however oncologists are not able to give prescription of unconventional agents as they are unaware of which patients would be responding to platinum treatment and which ones would not show any response to it. But, new-fangled study conducted at the Fox Chase Cancer Center indicates that ERCC-1 enzyme levels which aid in restoring cisplastin-linked DNA harm could provide an analytical indicator or marker of survival in case of head and neck cancer cases. The study outcomes could ultimately prove helpful in guiding therapy selection  [...]